Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,506.48
(
-1.51%
)
US TECH 100
23,484.80
(
-0.99%
)
Dow Jones
45,577.47
(
-0.96%
)
Brent Oil
106.93
(
0.00%
)
Bitcoin
70,721.18
(
0.29%
)
News Focus
News Focus
Post# of 19309
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 843
Posts 122806
Boards Moderated 10
Alias Born 09/05/2002

DewDiligence

Member Level

Re: y3maxx post# 1709

Friday, 11/03/2006 3:18:50 PM

Friday, November 03, 2006 3:18:50 PM

Post# of 19309
[OT] >IDIX seems more compelling at the moment. Assured revenue by 2010, ample cash on hand w/a bazzilion shorts on record.<

IDIX will have revenue from its approved drug (Tyzeka) in the current quarter: #msg-14283481.

Perhaps you meant to say profitability rather than revenue, but this too will come for IDIX before 2010.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today